In a recent decision, the Supreme Court dismissed a case challenging FDA approvals for the abortion pill mifepristone, ruling that anti-abortion groups lacked legal standing. The case could have limited access to the medication nationwide despite state laws. It's the first major abortion-related ruling since Roe v. Wade was overturned. Supporters argued FDA decisions were based on scientific judgment, while opponents cited health risks. Mifepristone is crucial in most U.S. abortions, affecting hormone levels for pregnancy termination up to 10 weeks. The court's move sidestepped judgment on FDA legality but maintained expanded medication access.
Bulletin brief
Unanimous Supreme Court preserve access to widely used abortion medication (AP)
Supreme Court rejects bid to restrict access to abortion pill (NBC)
